Innova Biosciences Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Innova Biosciences Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0126
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Innova Biosciences Ltd (Innova), a subsidiary of Sygnis AG is a provider of bioconjugation technologies and services. The company products include antibody labeling kits, antibody purification kits, affinity resins, gold nanoparticle kits, immunogen kits, rapid Ab labeling kits and others. It provides maleimide activated labels, substrates and stabilizers, phosphate detection, and oligonucleotide labeling kits for immuno-PCR. Innova offers technologies that simplify labelling of antibodies and other proteins to enzymes, fluorescent dyes, gold nanoparticles and oligonucleotides. The company’s technologies find application in immunoassays, flow cytometry, immunohistochemistry, fluorescence resonance energy transfer and nanoparticle tracking analysis. It caters to research laboratories, pharmaceutical, biotechnology and diagnostic companies. Innova is headquartered in Cambridge, the UK.

Innova Biosciences Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Innova Biosciences Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Innova Biosciences Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Innova Biosciences Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Innova Biosciences Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Innova Biosciences Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Innova Biosciences Ltd, Medical Equipment, Deal Details 10
Partnerships 10
VolitionRx Enters Into Licensing Agreement With Innova Biosciences For Biotin Technology 10
ImmunoReagents Enters Into Licensing Agreement With Innova Biosciences For Lightning-Link Technology 11
Mologic Enters into Licensing Agreement with Innova Biosciences 12
Equity Offering 13
Sygnis Raises USD6 Million in Private Placement of Shares 13
Acquisition 15
Sygnis Acquires Innova Biosciences from Innova Partnerships 15
Innova Biosciences Ltd – Key Competitors 16
Innova Biosciences Ltd – Key Employees 17
Innova Biosciences Ltd – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Product News 19
May 09, 2017: Innova Biosciences introduces the FlexLISA kit 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Innova Biosciences Ltd, Medical Equipment, Key Facts 2
Innova Biosciences Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Innova Biosciences Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Innova Biosciences Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Innova Biosciences Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Innova Biosciences Ltd, Deals By Market, 2012 to YTD 2018 8
Innova Biosciences Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
VolitionRx Enters Into Licensing Agreement With Innova Biosciences For Biotin Technology 10
ImmunoReagents Enters Into Licensing Agreement With Innova Biosciences For Lightning-Link Technology 11
Mologic Enters into Licensing Agreement with Innova Biosciences 12
Sygnis Raises USD6 Million in Private Placement of Shares 13
Sygnis Acquires Innova Biosciences from Innova Partnerships 15
Innova Biosciences Ltd, Key Competitors 16
Innova Biosciences Ltd, Key Employees 17

List of Figures
Innova Biosciences Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Innova Biosciences Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Innova Biosciences Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Innova Biosciences Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Innova Biosciences Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Innova Biosciences Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Innova Biosciences Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Innova Biosciences Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Innova Biosciences Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DexCom Inc (DXCM)-医療機器分野:企業M&A・提携分析
    Summary DexCom Inc (DexCom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. The company’s major products include DexCom G4, DexCom G4 Platinum and other continuous glucose monitoring syst …
  • Viridian Energy Supply Ltd:企業の戦略的SWOT分析
    Viridian Energy Supply Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Genome Institute of Singapore-製薬・医療分野:企業M&A・提携分析
    Summary Genome Institute of Singapore (GIS) is a research institute that provides various research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It handles the latest in technology and comprises early ca …
  • Sasol Ltd (SOL):企業の財務・戦略的SWOT分析
    Sasol Ltd (SOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Silver Peak Systems Inc:企業の戦略的SWOT分析
    Silver Peak Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Nippon Telegraph and Telephone Corporation:企業の戦略・SWOT・財務分析
    Nippon Telegraph and Telephone Corporation - Strategy, SWOT and Corporate Finance Report Summary Nippon Telegraph and Telephone Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • FieldPoint Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    FieldPoint Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary FieldPoint Petroleum Corp (FieldPoint) is an oil and gas company that acquires, operates and develops oil and gas properties. The company’s acquisition includes leasehold and working intere …
  • EnviroMission Ltd:企業の戦略的SWOT分析
    EnviroMission Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Quadrise Fuels International Plc (QFI):石油・ガス:M&Aディール及び事業提携情報
    Summary Quadrise Fuels International Plc (QFI), previously Zareba Plc, is an oil-in-water emulsified fuel developer that manufactures and markets MSAR (Multi phase Superfine Atomized Residue), an emulsion fuel as a low cost substitute for conventional heavy fuel oil (HFO) for use in power generation …
  • Purdue Pharma Canada:製薬・医療:M&Aディール及び事業提携情報
    Summary Purdue Pharma Canada, a subsidiary of Purdue Pharma LP is a research-based pharmaceutical company that offers services such as development, manufacturing and commercialization of medicines for patients and healthcare professionals. The company portfolio of products includes antiseptics, laxa …
  • Maxeda B.V.:戦略・SWOT・企業財務分析
    Maxeda B.V. - Strategy, SWOT and Corporate Finance Report Summary Maxeda B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • DSK Bank EAD :企業の戦略・SWOT・財務情報
    DSK Bank EAD - Strategy, SWOT and Corporate Finance Report Summary DSK Bank EAD - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Guerbet SA (GBT)-医療機器分野:企業M&A・提携分析
    Summary Guerbet SA (Guerbet) is a specialty pharmaceutical company which manufactures and markets medical imaging contrast agents destined for diagnostic purposes. The company provides a wide range of contrast agents for X-ray examinations and Magnetic Resonance Imaging (MRI). Guerbet also provides …
  • LeadFX Inc.:企業のM&A・事業提携・投資動向
    LeadFX Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LeadFX Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • WPG Holdings Limited:企業の戦略・SWOT・財務情報
    WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Edgars Stores Limited:企業の戦略・SWOT・財務情報
    Edgars Stores Limited - Strategy, SWOT and Corporate Finance Report Summary Edgars Stores Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Coherus BioSciences Inc (CHRS):企業の財務・戦略的SWOT分析
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • Onex Corporation:企業の戦略・SWOT・財務分析
    Onex Corporation - Strategy, SWOT and Corporate Finance Report Summary Onex Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Wells Fargo & Company:企業の戦略・SWOT・財務情報
    Wells Fargo & Company - Strategy, SWOT and Corporate Finance Report Summary Wells Fargo & Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Steris Plc (STE):医療機器:M&Aディール及び事業提携情報
    Summary Steris Plc (Steris), formerly Steris Ltd is a medical equipment company that provides infection prevention and other procedural products. The company offers products such as OR integration systems, sterilizers, surgical tables and lights, perioperative solutions, endoscopy accessories and ba …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆